12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids

OBJECTIVE: The prospective SONATA pivotal Investigational Device Exemption (IDE) trial was performed in the United States (US) and Mexico to examine the safety and effectiveness of transcervical fibroid ablation (TFA) in the treatment of symptomatic uterine fibroids. This is an analysis of 12-month...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Womens Health
Hlavní autoři: Hudgens, Joseph, Johns, D Alan, Lukes, Andrea S, Forstein, David A, Delvadia, Dipak
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616301/
https://ncbi.nlm.nih.gov/pubmed/31308763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S201912
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky